Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MDVN [NASD]
Medivation, Inc.
Index- P/E- EPS (ttm)-0.92 Insider Own2.69% Shs Outstand74.98M Perf Week-3.36%
Market Cap3.64B Forward P/E79.57 EPS next Y0.61 Insider Trans-4.72% Shs Float72.00M Perf Month-11.20%
Income-68.87M PEG- EPS next Q-0.22 Inst Own95.56% Short Float5.09% Perf Quarter-2.59%
Sales191.03M P/S19.05 EPS this Y-1.07% Inst Trans-1.05% Short Ratio2.94 Perf Half Y0.12%
Book/sh0.75 P/B64.72 EPS next Y161.00% ROA-17.74% Target Price68.88 Perf Year16.74%
Cash/sh3.62 P/C13.41 EPS next 5Y- ROE-100.24% 52W Range39.62 - 59.24 Perf YTD-5.12%
Dividend- P/FCF- EPS past 5Y0.00% ROI-23.99% 52W High-18.06% Beta0.96
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low22.51% ATR1.85
Employees257 Current Ratio3.54 Sales Q/Q25.33% Oper. Margin-25.99% RSI (14)44.31 Volatility3.97% 3.65%
OptionableYes Debt/Eq3.52 EPS Q/Q-6481.72% Profit Margin-36.05% Rel Volume1.11 Prev Close48.51
ShortableYes LT Debt/Eq3.52 EarningsMay 09 AMC Payout- Avg Volume1.25M Price48.54
Recom1.70 SMA20-5.48% SMA50-2.62% SMA200-5.48% Volume1,372,200 Change0.06%
04-Mar-13Initiated Needham Buy
19-Dec-12Initiated UBS Neutral $59
04-Dec-12Initiated Barclays Equal Weight $56
15-Nov-12Reiterated Aegis Capital Buy $90 → $100
25-Sep-12Reiterated Aegis Capital Buy $175 → $90
04-Sep-12Reiterated Brean Murray Buy $105 → $125
10-Nov-11Reiterated Rodman & Renshaw Mkt Underperform $19 → $29
03-Nov-11Upgrade Brean Murray Sell → Buy $6 → $77
18-Oct-11Initiated Summer Street Research Buy $27
16-Sep-11Initiated William Blair Outperform
07-Sep-11Initiated Morgan Joseph Buy $30
11-Apr-11Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform
10-Aug-10Reiterated Brean Murray Sell $8 → $6
26-Apr-10Upgrade Roth Capital Hold → Buy $10 → $14
04-Mar-10Downgrade JP Morgan Overweight → Neutral
03-Mar-10Downgrade Roth Capital Buy → Hold $34 → $10
03-Mar-10Downgrade Hapoalim Outperform → Neutral
05-Nov-09Upgrade Roth Capital Hold → Buy $21 → $34
29-Oct-09Initiated JP Morgan Overweight
12-May-09Reiterated Roth Capital Hold $17 → $21
20-May-13 04:40PM  Medivation's CEO Presents at UBS Global Healthcare Conference (Transcript) at Seeking Alpha
04:40PM  Medivation, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 01:00 PM at Seeking Alpha
17-May-13 01:04PM  MEDIVATION, INC. Financials EDGAR Online Financials
16-May-13 05:15PM  Bayer's Xofigo Cleared in the US Zacks
15-May-13 10:38AM  Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug at Bloomberg
14-May-13 11:16AM  Does Dendreon Still Have Potential? at Wall St. Cheat Sheet
06:13AM  The 8 Biggest Health Problems Americans Face at Motley Fool
13-May-13 04:10PM  Medivation Names Stephen Kelsey Senior Vice President of New Projects Marketwired
04:10PM  Medivation Names Stephen Kelsey Senior Vice President of New Projects Marketwire
09:27AM  Energy And Biotechs With Recent Earnings Catalysts at Seeking Alpha
08:10AM  Medivation Loss Narrower Than Expected Zacks
05:08AM  Medivation Inc. Stock Downgraded (MDVN) at TheStreet
12-May-13 11:14PM  MEDIVATION, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
11:55AM  Investors are Digesting These Healthcare Stock Earnings Insights at Wall St. Cheat Sheet
11-May-13 04:00PM  Dendreon: Picking Through the Carnage at Motley Fool
10-May-13 05:15PM  3 Horrendous Health-Care Stocks This Week at Motley Fool
05:01PM  Medivation Inc. (MDVN): Today's Featured Drugs Laggard at TheStreet
01:00PM  Little Left To Dendreon But The Hope Trade at Investopedia
09:17AM  MEDIVATION, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
02:20AM  Is Dendreon Done After Q1 Train Wreck? at Seeking Alpha
09-May-13 10:50PM  Medivation Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
05:58PM  Medivation Earnings: Heres Why the Stock is Falling Now at Wall St. Cheat Sheet
04:18PM  InPlay: Medivation beats by $0.09, beats on revs Briefing.com
04:10PM  Medivation Reports First Quarter Financial Results and Provides Corporate Update Marketwired
04:10PM  Medivation Reports First Quarter Financial Results and Provides Corporate Update Marketwire
02:17PM  This Biotech Is Looking for a Fourth-Quarter Comeback at Motley Fool
12:03PM  Dendreon: New Trial Sequencing Provenge With Xtandi To Begin Q4 at Seeking Alpha
09:18AM  MEDIVATION, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:19AM  Medivation Earnings: Your Sneak Peek to the Big Announcement at Wall St. Cheat Sheet
07:07AM  Q1 2013 Medivation, Inc. Earnings Release - After Market Close CCBN
08-May-13 10:59AM  Will Dendreon Ever Make Money? at Motley Fool
06-May-13 07:35PM  This Week's Must-Watch Stock: Dendreon at Motley Fool
04:10PM  Medivation Announces Participation at Upcoming Investor Conferences Marketwired
04:10PM  Medivation Announces Participation at Upcoming Investor Conferences Marketwire
10:40AM  Arena Pharma Narrows Loss Zacks
03-May-13 01:55PM  Eylea Drives Earnings at Regeneron Zacks
01:40PM  Narrower-Than-Expected Loss at Incyte Zacks
02-May-13 01:30PM  Wider-Than-Expected Loss at Pharmacyclics Zacks
01-May-13 04:49PM  Medivation Breaks Below 200-Day Moving Average - Notable For MDVN at TheStreet
11:00AM  Invest In The War On Cancer With These Stocks The StreetAuthority Network
11:00AM  Invest In The War On Cancer With These Stocks StreetAuthority Network
11:00AM  Invest In The War On Cancer With These Stocks
11:00AM  Fight Cancer, Save Lives With These Stocks The StreetAuthority Network
11:00AM  Fight Cancer, Save Lives With These Stocks
30-Apr-13 11:31AM  Finding Value in Biotech Pipelines: An Expert Analyst Discusses the Disconnect in the Biotech Sector in How Companies are Valued Relative to What They Can Do Wall Street Transcript
08:36AM  Europe Hands Down 2 Critical Drug Decisions at Motley Fool
29-Apr-13 04:10PM  Medivation Elects Wendy L. Yarno to Board of Directors Marketwired
04:10PM  Medivation Elects Wendy L. Yarno to Board of Directors Marketwire
09:19AM  MEDIVATION, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
28-Apr-13 11:45AM  This Week in Biotech at Motley Fool
26-Apr-13 11:50AM  William A. Hartman, President & Chief Executive Officer of Premier Biomedical, Inc. (BIEI), Interviews with The Wall Street Transcript Wall Street Transcript
11:49AM  Hedge Funds Are Buying These 2 Biotech Stocks at Seeking Alpha
09:07AM  MEDIVATION, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
08:23AM  UPDATE 1-EU body backs new Roche, Astellas, Sanofi, Vivus drugs at Reuters
02:14AM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
25-Apr-13 07:00AM  Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013 Marketwired
07:00AM  Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013 Marketwire
23-Apr-13 04:10PM  Medivation Elects Dawn Graham to Board of Directors Marketwired
04:10PM  Medivation Elects Dawn Graham to Board of Directors Marketwire
11:55AM  Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation Minyanville
09:18AM  MEDIVATION, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
22-Apr-13 01:20PM  How the bulls are trading Medivation optionMONSTER
01:14PM  How the bulls are trading Medivation optionMONSTER
09:18AM  MEDIVATION, INC. Files SEC form 8-K, Other Events EDGAR Online
20-Apr-13 03:48PM  Hedge Fund Adage Capital Managements Small Cap Picks at Motley Fool
18-Apr-13 03:16PM  Is Medivation Still A Buy? at Motley Fool
17-Apr-13 06:26PM  Medivation Inc. (MDVN): Today's Featured Health Care Mover at TheStreet
12-Apr-13 05:14AM  Medivation bull looks for more upside optionMONSTER
04:53AM  Medivation bull looks for more upside optionMONSTER
04:23AM  Medivation bull looks for more upside optionMONSTER
11-Apr-13 05:30AM  Adage Capital Management Owns 5.4% of This Biotech Stock at Motley Fool
10-Apr-13 12:18PM  In Insider Trading, LA's Wealthiest Man Buys Shares of JAKKS Pacific, and Yelp Sees a Sale at Minyanville
09:10AM  Top Insider Trades: JAKK SPB YELP MDVN at TheStreet
08-Apr-13 05:01PM  Medivation Inc. (MDVN): Drugs' Featured Underachiever Of The Day at TheStreet
03:30PM  5 stocks that hedge funds are buying at MarketWatch
07-Apr-13 11:00AM  Johnson & Johnson's Biggest Drug Rivals at Motley Fool
04-Apr-13 04:50PM  [video] Tomorrow in :30 at CNBC +5.79%
03:34PM  InPlay: Medivation: Adage Capital Partners discloses 5.37% passive stake in 13G filing Briefing.com
01:35PM  Sector Snap: Biotechnology stocks AP
03-Apr-13 11:43AM  Dendreon's Provenge Ads: Are They Working? at Seeking Alpha
02-Apr-13 04:16PM  Astellas/MDVN Provide Update on Xtandi Zacks
01-Apr-13 09:06AM  MEDIVATION, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:12AM  Medivation, Astellas Pharma provide update on Phase 3 PREVAIL theflyonthewall.com
07:00AM  Medivation and Astellas Provide Update on PREVAIL Marketwired
07:00AM  Medivation and Astellas Provide Update on PREVAIL Marketwire
25-Mar-13 02:03PM  A Magical Drug that Could Change Lives at Motley Fool
21-Mar-13 05:53PM  Good News for Nymox's Pipeline Zacks
20-Mar-13 04:55PM  Medivation Larger Than S&P 500 Component Allegheny Technologies at Forbes
01:00PM  Medivation: Still A Long But With Limited Upside at Seeking Alpha
19-Mar-13 03:43PM  Merck-Luminex' Alzheimer's Collaboration Zacks
12-Mar-13 06:33PM  What's Inside Johnson & Johnson's Pharmaceuticals Business? at Motley Fool
04:50PM  Medivation, Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2013 01:30 PM at Seeking Alpha
11-Mar-13 05:01PM  Medivation Inc. (MDVN): Today's Featured Health Care Laggard at TheStreet
04:33PM  Will Johnson & Johnson Help You Retire Rich? at Motley Fool
10:13AM  Revitalize Your Portfolio With This Drugmaker at Motley Fool
07-Mar-13 08:20AM  FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing Marketwire +5.52%
06-Mar-13 04:30PM  Medivation Announces Participation at Upcoming Investor Conference Marketwire
01:04PM  MEDIVATION, INC. Financials EDGAR Online Financials
10:02AM  Shocker! Sell-Sider Admits Dendreon Buy Rating Was Mistake at TheStreet
08:39AM  Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players at Motley Fool
Medivation, Inc., a biopharmaceutical company, focuses on development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients. The company also conducts various trials of enzalutamide in earlier prostate cancer disease states, including the Phase 3 PREVAIL trial in patients with mCRPC who have not received chemotherapy; and in patients with breast cancer. It has collaboration agreement with Astellas Pharma, Inc. for the development, manufacture, and commercialization of XTANDI. The company was founded in 2003 and is headquartered in San Francisco, California.